Autonomic Nervous System Drugs Practice Questions

Q: Which is the shortest acting beta-blocker?

Esmolol. **Explanation:** **Esmolol** is the shortest-acting beta-blocker due to its unique chemical structure. It is an ester, which allows it to be rapidly hydrolyzed by **red blood cell esterases** (not plasma cholinesterase). This results in an ultra-short half-life of approximately **9 minutes**. Because of this rapid metabolism, it must be administered via intravenous infusion and is easily titratable; if side effects occur, they resolve quickly once the infusion is stopped. **Analysis of Incorrect Options:** * **Propranolol:** A prototype non-selective beta-blocker with a half-life of 3–4 hours. It is lipid-soluble and undergoes significant first-pass metabolism. * **Timolol:** A non-selective beta-blocker primarily used topically for glaucoma. Its systemic half-life is approximately 4 hours. * **Atenolol:** A cardioselective (Beta-1) blocker that is water-soluble (hydrophilic) and excreted unchanged by the kidneys. It has a half-life of 6–9 hours, allowing for once-daily dosing. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Esmolol is the drug of choice for intraoperative tachycardia, hypertensive emergencies (especially aortic dissection), and supraventricular arrhythmias where rapid control is needed. * **Selectivity:** It is a **cardioselective (Beta-1)** antagonist. * **Metabolism:** Remember it is metabolized by **RBC esterases**. This makes it safe to use in patients with liver or kidney dysfunction. * **Longest acting beta-blocker:** Nadolol (half-life of 14–24 hours).

Q: All of the following statements about clonidine are true EXCEPT:

Prazosin completely antagonizes its action. ### Explanation **1. Why Option C is the Correct Answer (The False Statement):** Clonidine is a selective **$\alpha_2$-adrenergic agonist**. Its primary mechanism of action involves stimulating presynaptic $\alpha_2$ receptors in the nucleus tractus solitarius (NTS), which reduces sympathetic outflow. **Prazosin**, on the other hand, is a selective **$\alpha_1$-blocker**. Since they act on different receptor subtypes ($\alpha_2$ vs. $\alpha_1$), Prazosin does not antagonize the central antihypertensive effects of clonidine. The drug that can antagonize clonidine is **Yohimbine** (a selective $\alpha_2$-blocker). **2. Analysis of Incorrect Options (True Statements):** * **Option A:** Clonidine is indeed an **$\alpha$-adrenergic agonist**, specifically selective for the $\alpha_2$ subtype. * **Option B:** **Dry mouth (xerostomia)** and sedation are the two most common side effects of clonidine due to its central action and reduction of salivary secretions. * **Option D:** By stimulating central $\alpha_2$ receptors, clonidine **inhibits sympathetic outflow** from the vasomotor center in the medulla, leading to a decrease in blood pressure and heart rate. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rebound Hypertension:** Sudden withdrawal of clonidine can cause a hypertensive crisis due to a massive surge in catecholamines. This is managed by restarting clonidine or using **Phentolamine** (non-selective $\alpha$-blocker). * **Other Uses:** Apart from hypertension, clonidine is used in opioid withdrawal, ADHD, Tourette syndrome, and prophylaxis of migraine. * **Diagnostic Test:** The **Clonidine Suppression Test** is used to diagnose Pheochromocytoma (clonidine fails to suppress plasma catecholamines in these patients).

Q: Considering the therapies for myasthenia gravis, which one of the following adverse effects can be caused by neostigmine and pyridostigmine?

Diarrhea. **Explanation:** **Neostigmine** and **Pyridostigmine** are quaternary ammonium compounds that act as reversible acetylcholinesterase (AChE) inhibitors. By inhibiting the enzyme responsible for breaking down acetylcholine (ACh), they increase the concentration of ACh at both nicotinic and muscarinic receptors. **Why Diarrhea is Correct:** The gastrointestinal tract is rich in muscarinic ($M_3$) receptors. Increased ACh levels lead to increased intestinal motility and secretions. This parasympathetic overstimulation results in **diarrhea**, abdominal cramps, and nausea. This is a classic "SLUDGE" (Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis) side effect. **Analysis of Incorrect Options:** * **A. Bronchodilation:** ACh causes **bronchoconstriction** via $M_3$ receptors. Bronchodilation is a sympathetic effect (mediated by $\beta_2$ receptors). * **C. Cycloplegia:** Cycloplegia (paralysis of accommodation) is caused by anticholinergic drugs (e.g., Atropine). AChE inhibitors cause the opposite: **contraction of the ciliary muscle** (miosis and spasm of accommodation). * **D. Irreversible inhibition:** Neostigmine and Pyridostigmine are **reversible** carbamates. Irreversible inhibition is characteristic of Organophosphates (e.g., Malathion, Sarin). **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Pyridostigmine is the preferred long-term treatment for Myasthenia Gravis due to its longer duration of action and fewer GI side effects compared to Neostigmine. * **Management of Side Effects:** Muscarinic side effects (like diarrhea) can be managed by adding a small dose of **Atropine** or **Glycopyrrolate**. * **Edrophonium (Tensilon Test):** Used for diagnosis and to differentiate between Myasthenic crisis (improvement) and Cholinergic crisis (worsening).

Q: Which of the following drugs can be used to treat dry mouth associated with Sjögren syndrome?

Both. **Explanation:** The treatment of dry mouth (xerostomia) in Sjögren syndrome focuses on stimulating salivary secretions through the activation of **muscarinic receptors** (specifically M3) on salivary glands [1]. **Why the correct answer is "Both":** * **Pilocarpine:** A non-selective muscarinic agonist. It is a tertiary amine alkaloid that effectively stimulates secretions (salivary, sweat, and lacrimal) [1]. It is FDA-approved for xerostomia following head and neck radiation and for Sjögren syndrome. * **Cevimeline:** A synthetic muscarinic agonist with a higher affinity for **M3 receptors**. It has a longer duration of action and potentially fewer side effects (like sweating or cardiovascular effects) compared to pilocarpine. It is specifically indicated for the treatment of dry mouth in Sjögren syndrome. **Analysis of Options:** * **Option A & B:** Both are correct individually; however, since both are clinically used and FDA-approved for this condition, "Both" is the most accurate choice. * **Option D:** Incorrect, as these drugs are the mainstay of pharmacological management for sicca symptoms. **High-Yield Clinical Pearls for NEET-PG:** 1. **Contraindications:** Both drugs should be avoided in patients with uncontrolled asthma or COPD (due to bronchoconstriction) and acute iritis. 2. **Side Effects:** The most common side effect is **sweating (diaphoresis)**. 3. **Mnemonic:** Remember **"S-L-U-D-G-E"** (Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis) for cholinergic excess. 4. **Sjögren Syndrome Triad:** Dry eyes (xerophthalmia), dry mouth (xerostomia), and an associated autoimmune disease (like Rheumatoid Arthritis).

Q: Lid retraction is caused by which of the following medications?

Apraclonidine. **Explanation:** The correct answer is **Apraclonidine**. **Mechanism of Action:** Apraclonidine is a relatively selective **Alpha-2 (α2) adrenergic agonist** with weak **Alpha-1 (α1)** activity. While its primary use is to reduce intraocular pressure (IOP) by decreasing aqueous humor production, its α1-agonist activity stimulates the **superior tarsal muscle (Müller’s muscle)**. This smooth muscle is responsible for maintaining the elevation of the upper eyelid; its contraction results in **lid retraction** (widening of the palpebral fissure). This side effect is clinically significant and is sometimes used off-label to temporarily treat ptosis. **Analysis of Incorrect Options:** * **A & B (Bimatoprost and Latanoprost):** These are **Prostaglandin F2α analogues**. Their common ocular side effects include increased iris pigmentation, thickening/darkening of eyelashes, and **Prostaglandin-associated periorbitopathy (PAP)**, which typically causes a "sunken eye" appearance rather than lid retraction. * **C (Brimonidine):** While also an α2-agonist, Brimonidine is highly selective for α2 receptors and lacks the significant α1-stimulatory effect on Müller’s muscle required to cause lid retraction. **High-Yield Clinical Pearls for NEET-PG:** 1. **Apraclonidine Test:** Used in the diagnosis of **Horner’s Syndrome**. In a Horner’s eye (denervation supersensitivity), apraclonidine causes pupillary dilation and lid elevation, whereas it has little effect on a normal pupil. 2. **Tachyphylaxis:** Apraclonidine is generally used for short-term IOP control (e.g., post-laser surgery) because it frequently leads to loss of efficacy (tachyphylaxis) and high rates of local allergic reactions with chronic use. 3. **Mnemonic:** **A**praclonidine **A**cts on the eyelid (Retraction).

Q: Which of the following is considered a false neurotransmitter?

Tyramine. ### Explanation **Concept of False Neurotransmitters** A "false neurotransmitter" is a substance that is structurally similar to a natural neurotransmitter (like norepinephrine) and can be stored in synaptic vesicles but lacks the physiological potency to trigger a post-synaptic response [1]. **Tyramine (Correct Answer)** Tyramine is a metabolic byproduct of the amino acid tyrosine. Under normal conditions, it is metabolized by Monoamine Oxidase (MAO). However, if MAO is inhibited or if tyramine levels are excessively high, it is taken up into sympathetic nerve terminals via the **NET (Norepinephrine Transporter)** [1]. Inside the vesicle, it is converted into **octopamine**. Octopamine replaces norepinephrine in the vesicles but is significantly less potent at adrenergic receptors. When the nerve fires, octopamine is released instead of norepinephrine, failing to produce the expected sympathetic response. **Analysis of Incorrect Options** * **Epinephrine & Norepinephrine:** These are endogenous catecholamines and true neurotransmitters that act as potent agonists at alpha and beta-adrenergic receptors [1]. * **Dobutamine:** This is a synthetic catecholamine used clinically as a potent $\beta_1$ agonist. It is a direct-acting drug, not a substance that replaces endogenous transmitters in vesicles. **Clinical Pearls for NEET-PG** * **The Cheese Reaction:** Patients on MAO inhibitors (MAOIs) must avoid tyramine-rich foods (aged cheese, red wine). Tyramine displaces massive amounts of norepinephrine into the synapse, leading to a **hypertensive crisis**. * **Octopamine** is the specific molecule often cited as the "false neurotransmitter" derived from tyramine. * **Alpha-methyldopa** is another classic example; it is converted to $\alpha$-methylnorepinephrine, which acts as a false transmitter but also functions as a potent $\alpha_2$ agonist.

Q: A patient is diagnosed with benign prostatic hyperplasia (BPH). Which of the following medications provides symptomatic relief?

Terazosin. ### Explanation **Correct Answer: A. Terazosin** **Mechanism of Action:** Benign Prostatic Hyperplasia (BPH) involves two components: **static** (glandular enlargement) and **dynamic** (increased smooth muscle tone in the prostatic urethra and bladder neck). **Terazosin** is a non-selective **$\alpha_1$-adrenergic antagonist**. By blocking $\alpha_1$ receptors, it relaxes the smooth muscle of the bladder neck and prostate, thereby reducing urethral resistance and providing **rapid symptomatic relief** of lower urinary tract symptoms (LUTS). **Analysis of Incorrect Options:** * **B. Desmopressin:** This is a synthetic analog of ADH used primarily for central diabetes insipidus or nocturnal enuresis. It does not address the mechanical or dynamic obstruction of BPH. * **C. Finasteride:** This is a **5-$\alpha$ reductase inhibitor**. While it treats BPH by decreasing prostate volume (static component), it takes **6–12 months** to show clinical improvement. It is not used for immediate symptomatic relief. * **D. Sildenafil:** A PDE-5 inhibitor used for erectile dysfunction. While Tadalafil (another PDE-5 inhibitor) is FDA-approved for BPH, Sildenafil is not the standard first-line treatment for symptomatic relief in this context. **Clinical Pearls for NEET-PG:** * **First-line for symptoms:** $\alpha$-blockers (e.g., Tamsulosin, Alfuzosin) are the fastest-acting drugs for BPH symptoms. * **Selective vs. Non-selective:** Tamsulosin is $\alpha_{1A}$ selective (less hypotension); Terazosin/Doxazosin are non-selective and can cause **orthostatic hypotension** (First-dose phenomenon). * **Combination Therapy:** The MTOPS trial showed that combining an $\alpha$-blocker with a 5-$\alpha$ reductase inhibitor is superior in preventing disease progression. * **Side Effect:** $\alpha$-blockers are associated with **Floppy Iris Syndrome** during cataract surgery.

Q: Which muscarinic agonist is used in the treatment of angle closure glaucoma?

Pilocarpine. **Explanation:** **Pilocarpine** is the correct answer because it is a direct-acting **muscarinic agonist** (parasympathomimetic). In the management of primary angle-closure glaucoma (PACG), pilocarpine acts on the **sphincter pupillae** muscle to cause miosis. This pull on the iris tissue moves it away from the trabecular meshwork, effectively "opening" the angle and allowing the aqueous humor to drain. It also causes contraction of the ciliary muscle, which further facilitates aqueous outflow. **Analysis of Incorrect Options:** * **Neostigmine:** While it is a parasympathomimetic, it is an *indirect-acting* acetylcholinesterase inhibitor. It is primarily used in Myasthenia Gravis and is not a standard treatment for glaucoma due to poor ocular penetration and systemic side effects. * **Brimonidine:** This is a highly selective **alpha-2 adrenergic agonist**. It works by decreasing aqueous production and increasing uveoscleral outflow, but it is not a muscarinic agonist. * **Dipivefrine:** This is a prodrug of **epinephrine** (sympathomimetic). It is contraindicated in narrow-angle glaucoma because it can cause mydriasis, which may precipitate an acute attack. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** While Pilocarpine is used to break an acute attack, the definitive treatment for PACG is **Laser Peripheral Iridotomy (LPI)**. * **Concentration:** 1–2% Pilocarpine is typically used. Higher concentrations should be avoided as they may cause "vascular congestion," worsening the block. * **Side Effects:** Common side effects include **brow ache** (due to ciliary muscle spasm) and **accommodative myopia**. * **Contraindication:** Pilocarpine is generally avoided in **secondary glaucomas** like uveitic glaucoma, as it can increase the risk of posterior synechiae formation.

Question 1

Which is the shortest acting beta-blocker?

Accepted Answer

Esmolol

Answer

Propranolol

Answer

Timolol

Answer

Atenolol

Question 2

Cholinomimetics are useful in all the following conditions except?

Accepted Answer

Partial heart block

Answer

Glaucoma

Answer

Myasthenia gravis

Answer

Postoperative atony of bladder

Question 3

All of the following statements about clonidine are true EXCEPT:

Accepted Answer

Prazosin completely antagonizes its action

Answer

It is an alpha-adrenergic agonist

Answer

It can cause dry mouth as an adverse effect

Answer

It inhibits sympathetic outflow

Question 4

Considering the therapies for myasthenia gravis, which one of the following adverse effects can be caused by neostigmine and pyridostigmine?

Accepted Answer

Diarrhea

Answer

Bronchodilation

Answer

Cycloplegia

Answer

Irreversible inhibition of acetylcholinesterase

Question 5

Which of the following drugs can be used to treat dry mouth associated with Sjögren syndrome?

Accepted Answer

Both

Answer

Pilocarpine

Answer

Cevimeline

Answer

None

Question 6

Lid retraction is caused by which of the following medications?

Accepted Answer

Apraclonidine

Answer

Bimatoprost

Answer

Latanoprost

Answer

Brimonidine

Question 7

Which of the following is considered a false neurotransmitter?

Accepted Answer

Tyramine

Answer

Epinephrine

Answer

Norepinephrine

Answer

Dobutamine

Question 8

Intramuscular injection of atropine causes initial bradycardia. What is the reason for this effect?

Accepted Answer

Blockade of the muscarinic autoreceptor on vagal nerve endings

Answer

Stimulation of the medullary vagal center

Answer

Stimulation of vagal ganglia

Answer

Blockade of M2 receptors on SA nodal cells

Question 9

A patient is diagnosed with benign prostatic hyperplasia (BPH). Which of the following medications provides symptomatic relief?

Accepted Answer

Terazosin

Answer

Desmopressin

Answer

Finasteride

Answer

Sildenafil

Question 10

Which muscarinic agonist is used in the treatment of angle closure glaucoma?

Accepted Answer

Pilocarpine

Answer

Neostigmine

Answer

Brimonidine

Answer

Dipivefrine

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?